# Argenx SE: Form 20-F for the period ended Dec 31, 2020

- Company: [Argenx SE](/companies/argx.md) (CIK 1697862)
- Form: 20-F
- Filed: 2021-03-30
- Accepted by EDGAR: Mar 30, 2021, 16:55 ET
- Period: 2020-12-31
- Accession: 0001558370-21-003722
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1697862/000155837021003722/argx-20201231x20f.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1697862/000155837021003722/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2020-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Cash and equivalents | at 2020-12-31 | $576.1m | ifrs-full:CashAndCashEquivalents |
| Shares outstanding | at 2020-12-31 | 47,571,283 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1697862/000155837021003722/argx-20201231x20f.htm

Filed Mar 30, 2021.
Source: SEC EDGAR, the filing index for accession 0001558370-21-003722. Last ingested by Listed: Nov 9, 2026, 17:48 ET. No prices; not investment advice.
